We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+9.68%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$139M
AUM Growth
+$9.62M
(+7.4%)
Cap. Flow
+$2.42M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
27.84%
Holding
157
New
14
Increased
39
Reduced
52
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$2.49M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.34M |
| 3 |
GM
GEN MOTORS CORP
GM
|
+$2.05M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.37M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$1.98M |
| 2 |
Howard Hughes
HHH
|
+$1.7M |
| 3 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$1.39M |
| 4 |
Newmont
NEM
|
+$860K |
| 5 |
Corning
GLW
|
+$834K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.67% |
| 2 | Energy | 14.21% |
| 3 | Technology | 10.78% |
| 4 | Healthcare | 9.81% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GM
1
DELISTED
GEN MOTORS CORP
GM
| $5.98M | 4.3% |
166,350
+56,850
| +52% | +$2.05M |
|
|
2
Vodafone
VOD
$36.7B
| $4.08M | 2.93% |
113,747
+78,627
| +224% | +$2.49M |
|
3
GE Aerospace
GE
$356B
| $3.97M | 2.85% |
34,648
-668
| -2% | -$76.6K |
|
4
Hercules Capital
HTGC
$3.28B
| $3.83M | 2.75% |
251,296
-300
| -0.1% | -$4.35K |
|
5
BK Technologies
BKTI
$283M
| $3.79M | 2.72% |
287,511
+10,900
| +4% | +$163K |
|
|
CORE
6
DELISTED
Core Mark Holding Co., Inc.
CORE
| $3.77M | 2.71% |
227,200
| – | – |
|
7
Pfizer
PFE
$160B
| $3.46M | 2.48% |
126,849
-14,703
| -10% | -$400K |
|
8
Devon Energy
DVN
$51.8B
| $3.38M | 2.42% |
58,470
-1,225
| -2% | -$70K |
|
|
YHOO
9
DELISTED
Yahoo Inc
YHOO
| $3.35M | 2.41% |
101,000
+11,000
| +12% | +$311K |
|
10
Johnson & Johnson
JNJ
$640B
| $3.16M | 2.27% |
36,485
+5,400
| +17% | +$484K |
|
11
Clean Energy Fuels
CLNE
$353M
| $2.77M | 1.99% |
216,700
+8,000
| +4% | +$103K |
|
|
SPA
12
DELISTED
Sparton
SPA
| $2.64M | 1.9% |
103,702
-9,900
| -9% | -$196K |
|
|
HES
13
DELISTED
Hess
HES
| $2.55M | 1.83% |
33,000
+10,000
| +43% | +$745K |
|
|
14
Bristol-Myers Squibb
BMY
$137B
| $2.47M | 1.77% |
+53,400
| New | +$2.34M |
|
15
Cisco
CSCO
$442B
| $2.42M | 1.74% |
103,424
-12,450
| -11% | -$309K |
|
16
Mondelez International
MDLZ
$79.7B
| $2.41M | 1.73% |
76,650
-200
| -0.3% | -$6.2K |
|
17
Microsoft
MSFT
$3.75T
| $2.4M | 1.72% |
72,000
-25,077
| -26% | -$825K |
|
|
PCYC
18
DELISTED
PHARMACYCLICS INC
PCYC
| $2.38M | 1.71% |
17,250
+12,350
| +252% | +$1.37M |
|
19
Wells Fargo
WFC
$257B
| $2.37M | 1.7% |
57,275
-750
| -1% | -$32K |
|
20
Apple
AAPL
$4.59T
| $2.35M | 1.69% |
138,320
+27,160
| +24% | +$450K |
|
|
CVA
21
DELISTED
Covanta Holding Corporation
CVA
| $2.07M | 1.49% |
96,900
-25,200
| -21% | -$529K |
|
|
SDRL
22
DELISTED
Seadrill Limited Common Stock
SDRL
| $2M | 1.44% |
166
+16
| +11% | +$189K |
|
|
KRFT
23
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $1.99M | 1.43% |
37,937
-1,616
| -4% | -$88.5K |
|
|
CLNY
24
DELISTED
Colony Capital, Inc.
CLNY
| $1.88M | 1.35% |
93,900
+3,500
| +4% | +$70.7K |
|
|
RWT
25
Redwood Trust
RWT
$582M
| $1.74M | 1.25% |
88,400
-200
| -0.2% | -$3.56K |
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Benchmark Capital Advisors held 157 positions worth $139M, up 7.4% from $130M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Benchmark Capital Advisors's Q3 2013 filing shows 14 new, 39 increased, 52 reduced and 19 closed positions. Its largest new stake was Bristol-Myers Squibb: 53,400 shares worth $2.47M. The largest sale was Ligand Pharmaceuticals, an estimated $1.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 24% a quarter earlier, followed by Energy and Technology.
- Benchmark Capital Advisors's largest Q3 2013 buy was Bristol-Myers Squibb: 53,400 shares worth $2.47M.
- Benchmark Capital Advisors added most to Vodafone in Q3 2013, an estimated $2.49M increase.
- Benchmark Capital Advisors's biggest Q3 2013 reduction was Howard Hughes, cutting an estimated $1.7M.
- Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q3 2013, selling an estimated $1.98M.
- Benchmark Capital Advisors's ten largest holdings make up 28% of its $139M portfolio in Q3 2013.
- Benchmark Capital Advisors opened 14 new positions and closed 19 in Q3 2013.
- Benchmark Capital Advisors's portfolio value rose 7.4% quarter-over-quarter to $139M.
Based on Benchmark Capital Advisors's 13F filing for Q3 2013, filed 23 Oct 2013.